Researchers at the University of California, Davis have been awarded a $3 million National Science Foundation grant to pioneer groundbreaking technologies and workforce training programs aimed at cultivating plants in resource-limited environments both on Earth and in space. The project, known as Engineered Plants in Culture (EPiC), seeks to revolutionize biomanufacturing by leveraging the industrial potential of living organisms to generate biomolecules, biomaterials, and cellular products in a sustainable manner. This initiative represents a significant shift from the current highly complex and centralized biomanufacturing landscape in the United States, offering a novel approach to address the pressing need for accessible and cost-effective production systems.
Biomanufacturing has traditionally been confined to sophisticated facilities in a few key locations, necessitating substantial infrastructure, specialized expertise, and complex supply chains. The absence of biomanufacturing solutions tailored to low-resource settings has spurred the UC Davis team to explore innovative plant-based production systems that can thrive in diverse environments, ranging from rural communities to space stations. By harnessing the potential of engineered plant cells, embryos, and aquatic plants grown in controlled environments, EPiC aims to demonstrate the feasibility of sustainable bioproduction using minimal resources such as sunlight and carbon dioxide.
The EPiC project will investigate three distinct plant production platforms: transgenic rice cell suspension cultures, walnut embryo cultures, and fast-growing aquatic duckweed plants. These platforms hold the promise of not only advancing plant biomanufacturing but also enhancing traditional microbial and animal cell culture processes. Through a fusion of plant biology and bioprocess engineering, the researchers aim to overcome fundamental challenges in implementing this technology, facilitated by recent advancements in gene sequencing, synthesis, and editing techniques.
A key focus of EPiC is to enhance bioproduction efficiency, streamline cell line development, and promote sustainability by engineering plant cell lines, recycling biomass waste, and optimizing genetic modifications. The project will also introduce novel bioreactor designs that can be 3D printed cost-effectively and deployed locally, thus enhancing production scalability and accessibility. By developing commercial models for each production platform, the team aims to evaluate the economic viability of these innovative biomanufacturing solutions.
Led by Karen McDonald, a distinguished professor in the Department of Chemical Engineering, the EPiC project represents a culmination of decades of expertise and collaboration at UC Davis. The multidisciplinary team includes renowned experts such as Abhaya Dandekar from the Department of Plant Sciences, Stephen Robinson from the Department of Mechanical and Aerospace Engineering, and Denneal Jamison-McClung, the director of the UC Davis Biotechnology Program. Collaborations with Axiom Space and the Australian Research Council Centre of Excellence in Plants for Space further enrich the project by providing technical insights and educational support.
The involvement of Gavin D’Elia from Axiom Space underscores the project’s significance in exploring plant-based pharmaceutical production in microgravity environments, highlighting the potential for transformative discoveries both on Earth and beyond. By leveraging the unique conditions of space, EPiC aims to unlock novel pathways for sustainable biomanufacturing practices that could revolutionize various industries. This visionary approach aligns with the broader goals of the NSF Future Manufacturing program, which aims to drive fundamental research and workforce development to propel the future of U.S. manufacturing.
The NSF’s investment of $25.5 million in the Future Manufacturing program underscores the strategic importance of advancing biomanufacturing, cyber manufacturing, and eco-manufacturing initiatives to usher in a new era of manufacturing capabilities. Through collaborative efforts spanning multiple disciplines and institutions, the program seeks to catalyze transformative innovations that transcend conventional manufacturing paradigms. By nurturing convergence and interdisciplinary collaboration, the NSF aims to lay the foundation for manufacturing breakthroughs that could reshape industries and enhance global competitiveness.
In conclusion, the EPiC project at UC Davis epitomizes a bold leap towards sustainable and accessible plant biomanufacturing solutions that hold promise for addressing critical challenges both on Earth and in space. By combining cutting-edge research with educational outreach efforts, this initiative not only seeks to advance scientific knowledge but also inspire and train the next generation of innovators in the field of biomanufacturing. Through relentless dedication and visionary leadership, the UC Davis team is poised to redefine the boundaries of biotechnology and pave the way for a more sustainable and resilient future.
Takeaways:
– The EPiC project at UC Davis aims to pioneer sustainable plant biomanufacturing solutions for resource-limited environments.
– Leveraging engineered plant cells and novel bioproduction platforms, EPiC seeks to revolutionize traditional manufacturing processes.
– Collaborations with industry partners and space agencies highlight the project’s potential to drive transformative innovations in plant-based pharmaceutical production.
– The NSF’s Future Manufacturing program underscores the strategic focus on advancing biomanufacturing, cyber manufacturing, and eco-manufacturing initiatives to shape the future of U.S. manufacturing.
– By fostering convergence and interdisciplinary collaboration, the NSF aims to catalyze groundbreaking manufacturing capabilities that transcend current paradigms.
– The EPiC project represents a pinnacle of innovation and collaboration at UC Davis, signifying a significant step towards sustainable and accessible biomanufacturing solutions.
Read more on source